Zobrazeno 1 - 10
of 604
pro vyhledávání: '"anti-tumour necrosis factor"'
Autor:
Arteen Arzivian, Brett Jones, Fredrick Joshua, Miriam Paul, Thomas Lynch, Martin Brown, Robin Gasiorowski
Publikováno v:
Case Reports in Gastroenterology, Vol 18, Iss 1, Pp 221-230 (2024)
Introduction: Whipple’s disease is a rare condition that can present with atypical and non-specific features requiring a high index of suspicion for diagnosis. Case Presentation: We present a case of a man in his 40s with peripheral arthritis and b
Externí odkaz:
https://doaj.org/article/1fed07e14ca84d71893f28f11a6ddcba
Publikováno v:
Reumatismo (2024)
This case series aims to characterize the development of systemic lupus erythematosus (SLE) induced by anti-tumor necrosis factor α (anti-TNFα) therapy in patients with inflammatory rheumatic diseases, namely rheumatoid arthritis (RA), spondylarthr
Externí odkaz:
https://doaj.org/article/267684fb9ff74a6cb1d163f5ce8bbdb0
Autor:
Hsien-Tzung Liao, Chang-Youh Tsai
Publikováno v:
Bone & Joint Research, Vol 12, Iss 2, Pp 133-137 (2023)
Aims: To investigate the correlations among cytokines and regulatory T cells (T-regs) in ankylosing spondylitis (AS) patients, and their changes after anti-tumour necrosis factor-α (TNF-α) treatment. Methods: We included 72 AS patients with detaile
Externí odkaz:
https://doaj.org/article/1081b5f7b7474ca7ba21c1fe0d6cdf5e
Autor:
Helen Dakin, Ines Rombach, Melina Dritsaki, Alastair Gray, Catherine Ball, Sarah E. Lamb, Jagdeep Nanchahal
Publikováno v:
Bone & Joint Open, Vol 3, Iss 11, Pp 898-906 (2022)
Aims To estimate the potential cost-effectiveness of adalimumab compared with standard care alone for the treatment of early-stage Dupuytren’s disease (DD) and the value of further research from an NHS perspective. Methods We used data from the Rep
Externí odkaz:
https://doaj.org/article/76adb041d89d4c2e9bbfef39e6f55481
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Purpose: Anti-tumour necrosis factor-alpha (TNF-α) agents are often used for Behçet’s disease (BD) in clinical practice, but they have not been validated by a high level of evidence. We systematically reviewed published controlled trials to inves
Externí odkaz:
https://doaj.org/article/6fb31a324846457099acfed033041143
Autor:
Adriaan Volkers, Mark Löwenberg, Marlou Braad, Yara Abeling, Krisztina Gecse, Nicole Berkers, Nahid Montazeri, Geert D’Haens
Publikováno v:
Diagnostics, Vol 13, Iss 10, p 1712 (2023)
Background and aims: Point-of-care tests (POCT) allow instant measurement of inflammatory markers and drug concentrations. Here, we studied agreement between a novel POCT device and reference methods of measuring infliximab (IFX) and adalimumab (ADL)
Externí odkaz:
https://doaj.org/article/e6448056111e4d56bdf6bcebc9eaf899
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yudai Suzuki, Naoki Takasaka, Sachi Matsubayashi, Ayako Kojima, Kyota Shinfuku, Tsukasa Hasegawa, Masami Yamada, Ikumi Fujisaki, Aya Seki, Yoshitaka Seki, Takeo Ishikawa, Kazuyoshi Kuwano
Publikováno v:
Respirology Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract We herein report a case of allergic bronchopulmonary aspergillosis (ABPA) that occurred in a man treated with adalimumab for ankylosing spondylitis (AS). A 69‐year‐old man with a history of ankylosing spondylitis treated by adalimumab, a
Externí odkaz:
https://doaj.org/article/a3739e1bf5434725bdc9de241fcc17e6